title: OKT3 delays rejection crises after heart transplantation.
authors.affiliation: Transplantation Working Group, University Hospital Rotterdam-Dijkzigt, The Netherlands.
authors.forename: W
authors.initials: W
authors.lastname: Weimar
authors.forename: C E
authors.initials: CE
authors.lastname: Essed
authors.forename: A H
authors.initials: AH
authors.lastname: Balk
authors.forename: M L
authors.initials: ML
authors.lastname: Simoons
authors.forename: G F
authors.initials: GF
authors.lastname: Hendriks
authors.forename: G J
authors.initials: GJ
authors.lastname: Wenting
authors.forename: B
authors.initials: B
authors.lastname: Mochtar
authors.forename: E
authors.initials: E
authors.lastname: Bos
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use; D006084:Graft Rejection; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016853:Muromonab-CD3; D011183:Postoperative Complications / Q000517:prevention & control
chemical_list: D000911:Antibodies, Monoclonal; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3